Singleron Biotechnologies and Duckbill Inc have raised $30 million each in their fresh rounds of funding while Terminus Technologies has bagged an undisclosed sum from New York-based alternative investment firm Investcorp.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
